CN201302544Y - Micro-fluidic SPR bio-sensing device with high capture ratio and high sensitivity - Google Patents
Micro-fluidic SPR bio-sensing device with high capture ratio and high sensitivity Download PDFInfo
- Publication number
- CN201302544Y CN201302544Y CN 200820169047 CN200820169047U CN201302544Y CN 201302544 Y CN201302544 Y CN 201302544Y CN 200820169047 CN200820169047 CN 200820169047 CN 200820169047 U CN200820169047 U CN 200820169047U CN 201302544 Y CN201302544 Y CN 201302544Y
- Authority
- CN
- China
- Prior art keywords
- micro
- spr
- ctc
- fluidic
- metal film
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 230000035945 sensitivity Effects 0.000 title abstract description 11
- 239000002184 metal Substances 0.000 claims abstract description 38
- 239000000758 substrate Substances 0.000 claims abstract description 20
- 238000001514 detection method Methods 0.000 claims abstract description 15
- 239000007788 liquid Substances 0.000 claims description 14
- 230000003287 optical effect Effects 0.000 claims description 5
- 230000000886 photobiology Effects 0.000 claims description 5
- 238000005516 engineering process Methods 0.000 abstract description 23
- 206010028980 Neoplasm Diseases 0.000 abstract description 17
- 210000004369 blood Anatomy 0.000 abstract description 14
- 239000008280 blood Substances 0.000 abstract description 14
- 201000011510 cancer Diseases 0.000 abstract description 9
- 238000004458 analytical method Methods 0.000 abstract description 8
- 230000004907 flux Effects 0.000 abstract description 8
- 238000011161 development Methods 0.000 abstract description 6
- 238000012544 monitoring process Methods 0.000 abstract description 6
- 210000004027 cell Anatomy 0.000 abstract description 4
- 230000017531 blood circulation Effects 0.000 abstract description 3
- 230000001404 mediated effect Effects 0.000 abstract description 3
- 238000007689 inspection Methods 0.000 abstract description 2
- 238000011896 sensitive detection Methods 0.000 abstract description 2
- 210000004881 tumor cell Anatomy 0.000 abstract description 2
- 238000003491 array Methods 0.000 abstract 1
- 230000001351 cycling effect Effects 0.000 abstract 1
- 230000035876 healing Effects 0.000 abstract 1
- 238000005259 measurement Methods 0.000 abstract 1
- 238000002198 surface plasmon resonance spectroscopy Methods 0.000 description 66
- 208000005443 Circulating Neoplastic Cells Diseases 0.000 description 55
- 238000000034 method Methods 0.000 description 13
- 238000011282 treatment Methods 0.000 description 8
- 230000000694 effects Effects 0.000 description 6
- 238000012216 screening Methods 0.000 description 4
- 238000003745 diagnosis Methods 0.000 description 3
- 239000007850 fluorescent dye Substances 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 102000018651 Epithelial Cell Adhesion Molecule Human genes 0.000 description 2
- 108010066687 Epithelial Cell Adhesion Molecule Proteins 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 238000001574 biopsy Methods 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000002059 diagnostic imaging Methods 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- CXQXSVUQTKDNFP-UHFFFAOYSA-N octamethyltrisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 description 2
- 238000004987 plasma desorption mass spectroscopy Methods 0.000 description 2
- 238000012123 point-of-care testing Methods 0.000 description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 238000010008 shearing Methods 0.000 description 2
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 102000016289 Cell Adhesion Molecules Human genes 0.000 description 1
- 108010067225 Cell Adhesion Molecules Proteins 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 241000282414 Homo sapiens Species 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 206010061309 Neoplasm progression Diseases 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
- 235000018259 Solanum vestissimum Nutrition 0.000 description 1
- 240000002825 Solanum vestissimum Species 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 238000001815 biotherapy Methods 0.000 description 1
- 239000004568 cement Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000003989 dielectric material Substances 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000000835 electrochemical detection Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000000684 flow cytometry Methods 0.000 description 1
- 238000001415 gene therapy Methods 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000003365 immunocytochemistry Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- 238000002600 positron emission tomography Methods 0.000 description 1
- 238000007781 pre-processing Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000003375 selectivity assay Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229920005573 silicon-containing polymer Polymers 0.000 description 1
- 238000002174 soft lithography Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000001105 surface plasmon resonance spectrum Methods 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000005751 tumor progression Effects 0.000 description 1
Images
Landscapes
- Automatic Analysis And Handling Materials Therefor (AREA)
Abstract
The utility model discloses a micro-fluidic SPR bio-sensing device with high capture ratio and high sensitivity. Micro-fluidic chip technology is combined with SPR technology, and the lower end surface of a micro-structure substrate is provided with a tri-dimensional micro-passage structure which is formed by micro-post arrays, and the micro-structure substrate is connected with an SPR metal film below the micro-structure substrate to form a micro-fluidic SPR integrated chip. A micro-fluidic flow field which is mediated by the tri-dimensional micro-passage structure to control the flow direction and flow velocity of a cycling tumor cell (CTC), so that the contact rate and the combination rate between the CTC and the SPR metal film are improved on the premise of high flux of blood flow, and the measurement of the CTC is synchronically realized with the high sensitivity detection capacity of SPR, thereby realizing the high-efficient capturing and high sensitive detection of the CTC in trace amount. The micro-fluidic SPR bio-sensing device with high capture ratio and high sensitivity can promote the development of the micro-fluidic chip technology and the innovation of the cell analysis method, and can push forward the development of the bedside inspection technology and instrument, and is hopeful to utilize little blood to sieve the high risk group, and also can be used for dynamically monitoring the healing effect of the cancer patients.
Description
Technical field
The utility model relates to micro-fluidic chip technology, SPR (Surface Plasmon Resonance) sensing technology and microstructure flow field control technology, relates in particular to highly sensitive micro-fluidic SPR bio-sensing method of a kind of high capture radio and device.
Background technology
Malignant tumour is one of major disease of China's current serious harm humans life and health, although developed the serial therapy new tool that comprises immunization therapy, biological therapy and gene therapy, but the wholistic therapy effect of cancer patient does not have substantive the raising, and one of reason is the early detection of failing.In fact, China's cancer mortality growth in 30 years in the past reaches more than eighty per cant, and excess resource is used for middle and advanced stage patient's treatment.Discovery of tumour at present and diagnosis still highly depend on Medical Imaging, tumour-specific blood serum designated object and biopsy.The Medical Imaging method, as ultrasonic (US), computerized tomograph (CT), magnetic resonance video picture (MRI) and positron emission tomography (PET), have significant limitation on sensitivity and resolution, the lesion detection below a millimeter is less than, and expense costliness often.Based on the blood serum tumor markers detection method of molecular labeling and gene technology, be widely used in crowd's tumor screening, but the specificity of these marks is scarcely high, and exists safety issue.Biopsy is effective ways of making a definite diagnosis tumour, extensively adopts but this invasive inspection means are difficult to become conventional method.Therefore, research and develop simple, highly sensitive tumor screening method, development POCT required tumor screening and monitoring technology and instrument, to alleviating the pressure of the health care aspect that China faces, raising human beings'health level and quality of life play crucial effects.
Stage just has tumour cell to be shed to the circulation system to become circulating tumor cell (CTC), have correlativity with clinical indices such as tumor progression, curative effect monitoring, transfer and relapse and prognosis primary tumo(u)r in early days.But the cancer initial stage has only the very CTC of trace, realize that it successfully detects the capture efficiency that must improve CTC and the sensitivity of detecting instrument.External flow cytometry, fibre bundle scanning imagery art, immunocytochemistry detect, transcribe polymerase chain reaction,PCR, immunomagnetic isolation art etc. and all can be used for detecting CTC in the blood sample, but these methods often need the pre-service of blood, and CTC separation efficiency and purity also remain further to be improved.The characteristics of existing micro-fluidic chip technology are to handle micro-example, has the advantage that many other constant fluidicses such as integrated level height, the sample consumption is little, pollution is few are difficult to possess, but, and be not suitable for the express-analysis of big flux blood sample because the passage of micro-fluidic chip is generally in micron dimension.As 1 milliliter whole blood with the velocity flow of 1mm/s through the microchannel of 30 μ m * 30 μ m, need 12.9 days consuming time, can't satisfy the requirement of express-analysis.Recently Bao Dao CTC chip has been demonstrated the feasibility of directly capturing at whole blood sample enforcement high flux, high sensitivity CTC, is the impressive progress of micro-current controlled cell analytical approach.But, fluorescent dye and follow-up fluorescence microscope and CTC counting have been adopted in the detection of CTC, and this additional treatment step at trace CTC sample easily causes losing of CTC and pollutes, thereby directly influences the judgement of check result.And CTC captures and observes branch and comes and also restricted last analysis speed.The integrated micro-flow control technology is fundamental way and a great development trend that addresses this problem, as optics, Electrochemical Detection means are combined with micro-fluidic chip, perhaps with mass-spectrometric technique and micro-fluidic device coupling etc.
Summary of the invention
The purpose of this utility model is to provide highly sensitive micro-fluidic SPR bio-sensing method of a kind of high capture radio and device, with the CTC of trace in people at highest risk and the cancer initial stage patient's whole blood as capturing and detect object, the micro-fluidic chip technology is combined with the SPR technology, the flow direction and the speed of CTC is controlled in the micro-fluidic flow field of adopting three-dimensional Micro Channel Architecture to mediate, effectively improve the contact probability and the joint efficiency of CTC and SPR metal film, and the high-sensitivity detection ability of dependence SPR realizes the metering of CTC synchronously.
The purpose of this utility model is achieved by the following technical solution:
The highly sensitive micro-fluidic SPR Photobiology sensing device of a kind of high capture radio:
Comprise microstructure substrate, micro-pillar array, SPR metal film, liquid inlet, liquid outlet, incident light source, light path system and ccd detector; The three-dimensional Micro Channel Architecture that microstructure substrate lower surface has micro-pillar array to constitute, microstructure substrate and following SPR metal film sealing-in constitute micro-fluidic SPR integrated chip, two ends have liquid inlet and liquid outlet, SPR metal film lower end is provided with light path system, constitutes the optical detection system by incident light source, light path system and ccd detector.
In the described micro-pillar array microtrabeculae diameter with highly be 50 μ m, gap 50 μ m, per three microtrabeculaes all are triangular arranged, the spacing of microtrabeculae bottom surface and SPR metal film is 20 μ m.
Micro-fluidic chip is applied in the SPR device, the flow direction and the speed of CTC is controlled in the micro-fluidic flow field that the three-dimensional Micro Channel Architecture that adopts micro-pillar array to constitute mediates, with the lead surface of SPR metal film of CTC, and form suitable shearing force and duration of contact, therefore guaranteeing under the high-throughout prerequisite of blood flow, improve the contact probability and the joint efficiency of CTC and SPR metal film, rely on the metering of the high-sensitivity detection ability realization CTC of SPR device simultaneously, realize trace CTC high-level efficiency is captured and the highly sensitive target that detects synchronously; Described SPR metal film adheres to antibody, the specificity of high-affinity combines between antibody and the corresponding antigens, the SPR metal film ability that specificity is captured CTC will be given, the whole blood sample micro-fluidic SPR integrated chip of flowing through, CTC is constantly mediated by three-dimensional microstructures and flows to the SPR metallic film surface, and the antibody that is attached on the SPR metal film is captured.
Compare with background technology, the utlity model has following advantage:
1, the miniflow field control method of three-dimensional structure mediation is proposed, can realize fully contacting of CTC and SPR metal film under the big flow condition, and form suitable shearing force and duration of contact, to significantly improve the capture efficiency of SPR metal film, the flux that to alleviate in the conventional microfluidic channel and the contradiction between capture efficiency have been solved to CTC.
2, micro-fluidic chip technology and SPR technology are organically combined, can realize the double goal that trace CTC captures and detects, improve the analysis speed of CTC, avoid CTC to detect required fluorescent dye and fluorescence microscope process, avoid losing and polluting, thereby guarantee the reliability of check result at the additional treatments of trace CTC sample and the CTC that causes thus.
3, directly at the high flux of whole blood sample, high capture radio, high sensitivity CTC detection technique, avoided the preprocessing process of blood, it is the important innovations of cell analysis method and bio-sensing method, but be expected to utilize a small amount of blood just within a short period of time the people at highest risk to be implemented examination, the dynamic surveillance that also can be used for the cancer patient curative effect realizes " personalized treatment ".
Description of drawings
Fig. 1 is the synoptic diagram of the micro-fluidic SPR Photobiology of high capture radio high sensitivity described in the utility model sensing device.
Fig. 2 is the floor map of the micro-pillar array of micro-fluidic SPR integrated chip.
Among the figure: 1, microstructure substrate, 2, micro-pillar array, 3, the SPR metal film, 4, the liquid inlet, 5, liquid outlet, 6, incident light source, 7, light path system, 8, ccd detector.
Embodiment
Below in conjunction with drawings and Examples the utility model is further described:
As shown in Figure 1, micro-fluidic SPR Photobiology sensing device comprises microstructure substrate 1, micro-pillar array 2, SPR metal film 3, liquid inlet 4, liquid outlet 5, incident light source 6, light path system 7 and ccd detector 8.Microstructure substrate 1 constitutes micro-fluidic SPR integrated chip with following SPR metal film 3 sealing-ins, and incident light source 6, light path system 7 and ccd detector 8 constitute the optical detection systems.Whole blood sample with constant speed by pumping in micro-fluidic SPR integrated chip, microstructure substrate 1 adopts dimethyl silicone polymer (PDMS) as substrate material, the three-dimensional Micro Channel Architecture that microstructure substrate 1 lower surface has micro-pillar array 2 to constitute, microstructure area is rectangle, and yardstick is 10mm * 5mm.The arrangement of micro-pillar array 2 as shown in Figure 2, parameter is: the microtrabeculae diameter with highly be 50 μ m, gap 50 μ m, per three microtrabeculaes all are triangular arranged, microtrabeculae bottom surface and SPR metal film 3 spacings are 20 μ m.Because the PDMS substrate has certain elasticity, may cause contacting of microtrabeculae bottom surface and SPR metal film 3, cause microstructure to disturb the SPR detection signal, and change the Flow Field Distribution of three-dimensional microstructures mediation, restriction CTC passes through along SPR metal film 3 surfaces, and then reduces the capture efficiency of CTC.Therefore, the control chip channel width and increase the thickness and the hardness of microstructure substrate 1, with the stability of guaranteeing substrate and the stability of miniflow field.Microstructure substrate 1 adopts the preparation of SU-8 soft lithography, in order to form ladder-type structure, the SU-8 formpiston need by regulating the thickness of each layer SU-8 optical cement, can be regulated the distance of microtrabeculae height and microtrabeculae bottom surface and SPR metal film 3 by the repeatedly method making of even glue and multiexposure, multiple exposure.Microstructure substrate 1 is made back and SPR metal film 3 involutions, and has liquid inlet 4 and liquid outlet 5.
Big flux miniflow field control technology under the three-dimensional microstructures mediation is the key of micro-fluidic SPR integrated chip, also is to guarantee that CTC fully contacts the basic assurance that realization is efficiently captured with SPR metal film 3 in the big flux flow field.The design of micro-fluidic SPR integrated chip, take all factors into consideration micro-pillar shapes in the three-dimensional microstructures, highly, the factors such as spacing of yardstick, distribution density, arrangement mode and microtrabeculae bottom surface and SPR metal film 3, optimize chip design from aspects such as the mediation of circulation, microstructure stream field and capture conditionses, determine optimized three-dimensional microstructures parameter and service condition.
After CTC is captured by SPR metal film 3, realize the metering of CTC by the optical detection system synchronization of SPR.Because SPR is very responsive to the dielectric refractive index of metallic film surface, its surface plasma body resonant vibration angle of different dielectrics is also different.Dielectric of the same race, it is attached to the amount difference of metallic film surface, and then the response intensity of SPR is also different.So CTC is with after SPR metal film 3 surface antibodies combine, the displacement that the SPR spectrum peak generation that will cause ccd detector 8 to detect can observe, these information data transmission to computing machine, by analysis of spectrum can be real-time, quantitative, sensitive monitoring CTC and the interaction of SPR metal film 3.When so just having realized the CTC high-level efficiency captured, carry out synchronous high-sensitivity detection, improved the analysis speed of CTC, avoid conventional CTC to detect required fluorescent dye and fluorescence microscope process, avoid losing and polluting, thereby guarantee the reliability of check result at the additional treatments of trace CTC sample and the CTC that causes thus.
In sum, capture with high sensitivity and detect for solving under the high blood flow flux prerequisite high-level efficiency of trace CTC, the utility model organically combines micro-fluidic chip technology, SPR technology and microstructure flow field control technology, the purpose of introducing three-dimensional microstructures in microfluidic channel is to form the mediation of the micro-fluidic paired CTC in flow field, effectively improves the contact probability and the joint efficiency of CTC and SPR metal film 3.Microstructure is to the mediation of CTC, be similar to the baffle in the mixer structure, force effects such as the fluid element generation stretches, folds by three-dimensional microstructures, and form the guide effect to SPR metal film 3 thus to CTC, make that nearly all CTC has the chance that contacts with SPR metal film 3 in the fluid, avoid the generation of omission.The micro-fluidic chip and the SPR of microstructure mediation is integrated, rely on the high-sensitivity detection ability of SPR to realize that the high sensitivity of CTC detects, and finishes CTC and captures and detect double goal on one chip.
This novel bio-sensing method that the utility model proposes, with in people at highest risk and the cancer initial stage patient's whole blood very the CTC of trace as capturing and detect object, be expected to develop into the new technology of quick enforcement tumour early screening and monitoring, the development of POCT technology and instrument will be advanced, promote the successful implementation of the early stage diagnosis and treatment development strategy of China's tumour, also can be used for the highly sensitive detection and the fields such as medical treatment, environment and safety monitoring of biochemical molecular.
Claims (2)
1, the highly sensitive micro-fluidic SPR Photobiology sensing device of a kind of high capture radio is characterized in that: comprise microstructure substrate (1), micro-pillar array (2), SPR metal film (3), liquid inlet (4), liquid outlet (5), incident light source (6), light path system (7) and ccd detector (8); The three-dimensional Micro Channel Architecture that microstructure substrate (1) lower surface has micro-pillar array (2) to constitute, microstructure substrate (1) constitutes micro-fluidic SPR integrated chip with following SPR metal film (3) sealing-in, two ends have liquid inlet (4) and liquid outlet (5), SPR metal film (3) lower end is provided with light path system (7), constitutes the optical detection system by incident light source (6), light path system (7) and ccd detector (8).
2, the highly sensitive micro-fluidic SPR Photobiology sensing device of a kind of high capture radio according to claim 1, it is characterized in that: in the described micro-pillar array (2) the microtrabeculae diameter with highly be 50 μ m, gap 50 μ m, per three microtrabeculaes all are triangular arranged, and the spacing of microtrabeculae bottom surface and SPR metal film (3) is 20 μ m.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200820169047 CN201302544Y (en) | 2008-12-04 | 2008-12-04 | Micro-fluidic SPR bio-sensing device with high capture ratio and high sensitivity |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200820169047 CN201302544Y (en) | 2008-12-04 | 2008-12-04 | Micro-fluidic SPR bio-sensing device with high capture ratio and high sensitivity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN201302544Y true CN201302544Y (en) | 2009-09-02 |
Family
ID=41086171
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200820169047 Expired - Lifetime CN201302544Y (en) | 2008-12-04 | 2008-12-04 | Micro-fluidic SPR bio-sensing device with high capture ratio and high sensitivity |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN201302544Y (en) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8771491B2 (en) | 2009-09-30 | 2014-07-08 | Quantapore, Inc. | Ultrafast sequencing of biological polymers using a labeled nanopore |
| CN104155266A (en) * | 2014-08-29 | 2014-11-19 | 西安交通大学 | Multichannel parallel detection surface plasma resonance biosensor, and preparation and detection methods thereof |
| US9624537B2 (en) | 2014-10-24 | 2017-04-18 | Quantapore, Inc. | Efficient optical analysis of polymers using arrays of nanostructures |
| US9651539B2 (en) | 2012-10-28 | 2017-05-16 | Quantapore, Inc. | Reducing background fluorescence in MEMS materials by low energy ion beam treatment |
| US9862997B2 (en) | 2013-05-24 | 2018-01-09 | Quantapore, Inc. | Nanopore-based nucleic acid analysis with mixed FRET detection |
| US9885079B2 (en) | 2014-10-10 | 2018-02-06 | Quantapore, Inc. | Nanopore-based polymer analysis with mutually-quenching fluorescent labels |
| US9903820B2 (en) | 2007-05-08 | 2018-02-27 | The Trustees Of Boston University | Chemical functionalization of solid-state nanopores and nanopore arrays and applications thereof |
| US10823721B2 (en) | 2016-07-05 | 2020-11-03 | Quantapore, Inc. | Optically based nanopore sequencing |
-
2008
- 2008-12-04 CN CN 200820169047 patent/CN201302544Y/en not_active Expired - Lifetime
Cited By (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11002724B2 (en) | 2007-05-08 | 2021-05-11 | Trustees Of Boston University | Chemical functionalization of solid-state nanopores and nanopore arrays and applications thereof |
| US10101315B2 (en) | 2007-05-08 | 2018-10-16 | Trustees Of Boston University | Chemical functionalization of solid-state nanopores and nanopore arrays and applications thereof |
| US9903820B2 (en) | 2007-05-08 | 2018-02-27 | The Trustees Of Boston University | Chemical functionalization of solid-state nanopores and nanopore arrays and applications thereof |
| US8771491B2 (en) | 2009-09-30 | 2014-07-08 | Quantapore, Inc. | Ultrafast sequencing of biological polymers using a labeled nanopore |
| US9279153B2 (en) | 2009-09-30 | 2016-03-08 | Quantapore, Inc. | Ultrafast sequencing of biological polymers using a labeled nanopore |
| US9651539B2 (en) | 2012-10-28 | 2017-05-16 | Quantapore, Inc. | Reducing background fluorescence in MEMS materials by low energy ion beam treatment |
| US9862997B2 (en) | 2013-05-24 | 2018-01-09 | Quantapore, Inc. | Nanopore-based nucleic acid analysis with mixed FRET detection |
| CN104155266B (en) * | 2014-08-29 | 2016-08-24 | 西安交通大学 | A kind of multi-channel parallel detects surface plasma resonance biosensor and preparation thereof and detection method |
| CN104155266A (en) * | 2014-08-29 | 2014-11-19 | 西安交通大学 | Multichannel parallel detection surface plasma resonance biosensor, and preparation and detection methods thereof |
| US9885079B2 (en) | 2014-10-10 | 2018-02-06 | Quantapore, Inc. | Nanopore-based polymer analysis with mutually-quenching fluorescent labels |
| US10597712B2 (en) | 2014-10-10 | 2020-03-24 | Quantapore, Inc. | Nanopore-based polymer analysis with mutually-quenching fluorescent labels |
| US9624537B2 (en) | 2014-10-24 | 2017-04-18 | Quantapore, Inc. | Efficient optical analysis of polymers using arrays of nanostructures |
| US11041197B2 (en) | 2014-10-24 | 2021-06-22 | Quantapore, Inc. | Efficient optical analysis of polymers using arrays of nanostructures |
| US10823721B2 (en) | 2016-07-05 | 2020-11-03 | Quantapore, Inc. | Optically based nanopore sequencing |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101419167B (en) | High capture rate and high-sensitivity microflow control SPR bio-sensing method and device | |
| CN201302544Y (en) | Micro-fluidic SPR bio-sensing device with high capture ratio and high sensitivity | |
| Bankó et al. | Technologies for circulating tumor cell separation from whole blood | |
| Hartjes et al. | Extracellular vesicle quantification and characterization: common methods and emerging approaches | |
| CN105848793B (en) | Material selectivity is delivered to cell | |
| JP6139616B2 (en) | Medical devices for analyte monitoring and drug delivery | |
| JP6177529B2 (en) | Assay device with multiple reagent cells | |
| CN103604775B (en) | Micro-fluid chip-based microorganism detection instrument and SPR detection method thereof | |
| BRPI0709600A2 (en) | Devices and methods for detecting cells and other analytes | |
| WO2019196270A1 (en) | Micro-nano particles detection system and method thereof | |
| CN109486653A (en) | Trace cell capture system based on micro-fluidic and immune Magneto separate dual strategy | |
| US20210041356A1 (en) | Plasmon waveguide, biosensor chip and system | |
| JP2013148584A (en) | Assay device having uniform flow around corners | |
| Cho et al. | Microfluidic chip-based cancer diagnosis and prediction of relapse by detecting circulating tumor cells and circulating cancer stem cells | |
| JP2021512299A (en) | Parallel assay of cells and non-cell analysts in a sample | |
| EP3607299A1 (en) | Optofluidic device and method for detecting circulating tumour cells | |
| Du et al. | Recognition and capture of breast cancer cells using an antibody-based platform in a microelectromechanical systems device | |
| Wessels et al. | Recent advances in point of care diagnostic tools: A review | |
| Ideno et al. | Early detection of pancreatic cancer: role of biomarkers in pancreatic fluid samples | |
| JP2013148585A (en) | Low volume assay device having increased sensitivity | |
| Guo et al. | Recent progress of nanostructure-based enrichment of circulating tumor cells and downstream analysis | |
| Qiu et al. | Current advances in technologies for single extracellular vesicle analysis and its clinical applications in cancer diagnosis | |
| KR101635510B1 (en) | In-line lab-on-a-chip system for measuring a difference in speed according to slip of red blood cell membrane and there of optical detection system | |
| TWM583855U (en) | Micro-runner chip and micro-runner structure with uneven structure | |
| US20240157358A1 (en) | Biosensing system and method for in-situ determination of metastasis in a sample |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| AV01 | Patent right actively abandoned |
Granted publication date: 20090902 Effective date of abandoning: 20081204 |